SNT 0.00% 3.5¢ syntara limited

Ann: Pharmaxis Acquires Control, Increases Stake in LOXL2 Program, page-6

  1. 7,045 Posts.
    lightbulb Created with Sketch. 538
    1. Interest of LOXL2 from Pharmas are intensified.
    2. Synairgen has near-term cash problem, and happy to sacrifice long term potential in LOXL2 for badly needed cash, which PXS happen to have in the bank.

    Early-mid 2018 will be interesting for PXS, when multiple trails approaching the results.
    Last edited by newB: 24/12/17
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
3.5¢
Change
0.000(0.00%)
Mkt cap ! $45.16M
Open High Low Value Volume
3.6¢ 3.6¢ 3.3¢ $58.54K 1.668M

Buyers (Bids)

No. Vol. Price($)
1 5226 3.5¢
 

Sellers (Offers)

Price($) Vol. No.
3.6¢ 969288 2
View Market Depth
Last trade - 16.10pm 27/08/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.